No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
PATH241213C13000
- 1.15
- -0.77-40.10%
15min DelayTrading Dec 12 14:23 ET
1.30High1.15Low
1.30Open1.92Pre Close15 Volume298 Open Interest13.00Strike Price1.77KTurnover126.90%IV0.00%PremiumDec 13, 2024Expiry Date1.15Intrinsic Value100Multiplier1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.8944Delta0.1894Gamma11.37Leverage Ratio-0.0517Theta0.0003Rho10.16Eff Leverage0.0014Vega
Intraday
- 5D
- Daily
News
UiPath Initiated at Sell by UBS
UiPath Analyst Ratings
UBS Initiates UiPath(PATH.US) With Sell Rating, Announces Target Price $14
Uipath Insider Sold Shares Worth $858,699, According to a Recent SEC Filing
2025 Investment Themes: AI, Energy, Defense Redefine US Markets
Why UiPath (PATH) Might Be Well Poised for a Surge